Spinal Cord Stimulator Market to Witness an Outstanding Growth by 2025
The spinal cord stimulator hinders transmission of pain signals to the brain so that the brain does not identify the pain. The device gives positive, symptomatic, and long-term effects in cases of sciatica, cervical radiculopathy, failed back surgery syndrome (FBSS), reflex sympathetic dystrophy, arachnoiditis, and peripheral neuropathy. Spinal cord stimulation received approval from the U.S. FDA in 1989 for indications such as nerve damage in the trunk, arms, or legs. According to a study conducted by the Institute of Medicine...
View full press release